Literature DB >> 10225718

A study of the efficacy of plasmapheresis for the treatment of drug induced toxic epidermal necrolysis.

H Yamada1, K Takamori, H Yaguchi, H Ogawa.   

Abstract

The efficacy of plasmapheresis for the treatment of toxic epidermal necrolysis (TEN) in our patient and related reports in the literature were examined. The patient, a 41-year-old female, was diagnosed as having drug (Sedes-G [isopropylantipyrin, arylisopropylacetoureid, and phenacetinum]) induced TEN. Upon admission to our hospital, extensive corticostroid therapy was initiated. After 6 days, because more than 90% of the patient's body surface was affected by TEN, it was concluded that the patient was unresponsive to corticosteroid therapy. Double filtration plasmapheresis (DFPP) was therefore begun. After 2 sessions of DFPP, extensive reepithelialization rapidly occurred, and after 3 sessions of DFPP, the improvement was dramatic. The patient's condition had almost healed during 1 month's hospitalization. It has been reported in the literature that 22 patients with drug induced TEN have been treated with plasmapheresis. The mortality rate of 23 patients, including our patient, was 17.4%. The rate of effectiveness of plasmapheresis on drug induced TEN is 82.6%. It appears that some kind of necrolytic factors were removed by the plasmapheresis. This suggests that plasmapheresis may be an effective treatment for drug induced TEN.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10225718     DOI: 10.1111/j.1744-9987.1998.tb00094.x

Source DB:  PubMed          Journal:  Ther Apher        ISSN: 1091-6660


  5 in total

1.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

Review 2.  Toxic epidermal necrolysis and Stevens-Johnson syndrome.

Authors:  Thomas Harr; Lars E French
Journal:  Orphanet J Rare Dis       Date:  2010-12-16       Impact factor: 4.123

Review 3.  Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Akito Hasegawa; Riichiro Abe
Journal:  F1000Res       Date:  2020-06-16

4.  Development of an electronic medical record-based algorithm to identify patients with Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan.

Authors:  Toshiki Fukasawa; Hayato Takahashi; Norin Kameyama; Risa Fukuda; Shihori Furuhata; Nanae Tanemura; Masayuki Amagai; Hisashi Urushihara
Journal:  PLoS One       Date:  2019-08-13       Impact factor: 3.240

Review 5.  A contemporary snippet on clinical presentation and management of toxic epidermal necrolysis.

Authors:  Piyu Parth Naik
Journal:  Scars Burn Heal       Date:  2022-09-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.